Warning letter
Oza Compound Products, LLC: warning letter of Jun 7, 2012
FDA warning letter 276996 · Detroit District Office
Key facts
| Reference number | 276996 |
|---|---|
| Company | Oza Compound Products, LLC |
| Subject | CGMP for Dietary Supplement/Adulterated/Misbranded |
| Issue date | Jun 7, 2012 |
| Posted date | Jun 7, 2012 |
| Issuing office | Detroit District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.260(j)(2)(iii), 101, 101.36, 111, 111.70, 111.73, 111.103, 111.260, 101.3(g), 101.9, 101.4(g), 111.70(b)(1) and 19 more |
| Inspection city | Fort Wayne |
| Inspection ZIP | 46808 |
| Inspection start date | Jan 18, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: